MPH Program graduate receives Excellence in Mentoring Translational Scientists Award

November 5, 2015

Tina Hartert, M.D., MPH, assistant vice chancellor for Translational Science and director of the Vanderbilt Center for Asthma and Environmental Health Research, was honored on Oct. 30 during the annual Vanderbilt Translational Research Forum, a celebration and showcase of research that brings the fruits of lab bench science to the patient’s bedside. Dr. Hartert s the first recipient of the Excellence in Mentoring Translational Scientists Award.

The Washington Post: MPH's Schaffner advises adults to get vaccinated

November 4, 2015

Some adult vaccines are boosters, building your immunity against those illnesses. Others protect against diseases that are more common in adulthood. All adults should have these key vaccines, according to the Centers for Disease Control and Prevention: an annual flu shot; a Td booster every 10 years to ward off tetanus and diphtheria; a zoster vaccine at age 60 to guard against shingles; and the pneumococcal vaccine at age 65 to protect against a type of pneumonia.

In The Atlantic: MPH student advocates making indigenous peoples equal partners in gene reserach

October 27, 2015

Speaking at the 2015 meeting of the American Society for Human Genetics (ASHG), Krystal Tsosie from Vanderbilt University said the case of The Akimel O’odham (Pima), a group of Native Americans from Arizona, withdrawing their partnership with the NIH in 2003, and signing a $5 million agreement with a non-profit organization called the Translational Genomics Research Institute (TGen), exemplified how indigenous groups are taking charge of their fates in the world of modern genetics. “The Tribe approached the researchers, not vice versa,” she said.

NashvilleHealth gets help from MPH Program's Buntin

October 26, 2015

Former Senator Bill Frist wants to improve the overall health of the entire city by putting healthy living in the public consciousness and helping Nashville’s sickest and most disadvantaged citizens. Working with MPH Program's Melinda Buntin on the data and research behind the initiatives, Frist wants NashvilleHealth to focus, at first, on hypertension, smoking cessation and child health.

MPH Program student testing new treatment for Alzheimer's

October 23, 2015

Researchers say a new drug, T-817, is on the horizon to slow the progression of Alzheimer's disease, and Vanderbilt is one of 50 clinical trial sites across the country testing the drug. "It's basically a drug that is shown to have neuro-protective effects to prevent the early death of those brain cells that we're trying to protect in patients with Alzheimer's disease," said Vanderbilt researcher Dr. Leah Acosta.    

MPH Program graduate: One standard needed to track concussions

October 22, 2015

Data in sports concussion studies will continue to be disputed as long as the injuries are diagnosed by differing standards instead of universal guidelines. That’s the conclusion of Oscar D. Guillamondegui, M.D., MPH, associate professor of Neurological Surgery at Vanderbilt, in a review of a study on concussion incidence among peewee, youth and college football players. The review appeared Oct. 6 in the Journal of the American Medical Association (JAMA), the parent publication to JAMA Pediatrics, which published the study in July.

NBC talks to MPH's Schaffner about $1.6 billion effort to prevent the flu this season

October 20, 2015

The process of putting the flu vaccine together begins in February, when the World Health Organization determines which strains of the virus should be included, based on what's circulating around the globe. Dr. William Schaffner, medical director of the National Foundation for Infectious Diseases, explains that "flu is fickle. Last season was unusual because not only did we have one strain of influenza that caused almost all of the reported flu cases, but it was different — it had mutated — so it was different than the strain that was represented in the vaccine."

IDWeek: MPH Program graduate learned from last year's "not perfect" flu vax

October 16, 2015

The flu vaccine last season was almost completely ineffective at preventing the disease, but it might have helped some people stay out of hospital, researchers reported here."The flu vaccine is not perfect and it varies in efficacy from year to year," commented H. Keipp Talbot, MD, MPH, of Vanderbilt University School of Medicine in Nashville. If there's a clinical lesson from the 2014-15 flu season, it's that people should get their shot, but if they get the flu, their doctors should consider antiviral medications.

Halloween treat Listeria connection low states MPH Program's Schaffner

October 14, 2015

A deadly 2014 Listeria outbreak linked to caramel apples has puzzled researchers attempting to understand how the favorite Halloween treat could be the source of the deadly bacteria. The 2014 outbreak left at least seven dead and 35 infected, according to the U.S. Centers for Disease Control and Prevention.